Log in  First Connection?

BreastArchives

Redefining breast cancer screening: advances in risk stratification and personalisation
Breast
 1 min.

 Published on 30/06/2026 |  Original article (Full-text)  | Ageely et al. | Egyptian Journal of Radiology and Nuclear Medicine. Volume 56(1).

Conventional breast cancer (BC) screening approaches, primarily based on age criteria, often fail to consider individual variability in risk. This results in challenges such as overdiagnosis and false-positive results. Aim: This review aimed to explore strategies for risk-stratified breast cancer screening...

Fatty acid synthase-derived lipid stores support breast cancer metastasis
Breast
 1 min.

 Published on 23/06/2026 |  Original article (Full-text)  | Andolino, Chaylen et al. | Cancer & Metabolism. Volume 13(1).

Lipid accumulation is associated with breast cancer metastasis. However, the mechanisms underlying how breast cancer cells increase lipid stores and their functional role in disease progression remain incompletely understood. Herein we quantified changes in lipid metabolism and characterized cytoplasmic...

Ligand-functionalized liposomal vesicles in breast cancer: advances in targeted nanotherapeutics
Breast
 1 min.

 Published on 16/06/2026 |  Original article (Full-text)  | Rohit Sharma et al. | Expert Opinion on Drug Delivery 2026; aop:10.1080/17425247.2026.2685776

Breast cancer (BC) remains one of the most prevalent malignancies worldwide, characterized by molecular heterogeneity, therapeutic resistance, and high recurrence rates that limit the success of conventional treatments. Although chemotherapy and targeted therapies have improved patient outcomes, their...

Biomarker-driven and AI-assisted nanomedicine for breast cancer: advancing precision drug delivery from bench to bedside
Breast
 1 min.

 Published on 09/06/2026 |  Original article (Full-text)  | Jaleh Barar et al. | Expert Opinion on Drug Delivery 2026; aop:10.1080/17425247.2026.2680061

Breast cancer remains the most prevalent malignancy among women worldwide, with its pronounced molecular heterogeneity demanding therapeutic strategies that transcend conventional systemic chemotherapy toward tumor-selective, molecularly precise interventions. The convergence of biomarker science, engineered...